جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

2 مُخرَج نتائج البحث عن «Genotype»

مراجعةوصول مغلق2026

Progress and Innovation in Japanese Encephalitis Vaccines: Toward Global Immunization

Recent Advances in Anti-Infective Drug Discovery · مجلد 21 (3) · 205-219

Japanese encephalitis (JE) remains a major public health concern, especially in Asia and the Western Pacific, where more than 3 billion people are at risk. Despite advances in vaccine development, challenges such as viral strain diversity, limited crossprotection, and access barriers persist. JE directly impacts economic development because disease patterns are influenced by factors such as healthcare infrastructure, surveillance, vaccine availability, and agricultural trends across low-, middle-, upper-, and high-income countries. Current vaccines primarily target genotype III strains, but genotype I has become dominant in many endemic areas, raising concerns about vaccine efficacy. Furthermore, the need for booster doses, cold chain storage requirements, and high production costs all contribute to limited immunization coverage. Recent innovations, including thermostable formulations, multivalent vaccines, and mRNA-based candidates, offer promising solutions for JE prevention. Global initiatives by organizations such as WHO, GAVI, and PATH have played a critical role in increasing vaccine accessibility, yet gaps remain in achieving universal coverage. This review addresses the progress, challenges, and emerging strategies in JE vaccine development, emphasizing the importance of innovative approaches to ensure global protection against this life-threatening disease.

Japanese encephalitisJE vaccinevaccine developmentgenotype I
مقالوصول مغلق2025

Angiotensin‐Converting Enzyme 2 (G8790A) Gene Polymorphism as a Risk Factor for COVID‐19 in Egyptian Children and Adolescents

Pediatric Pulmonology · مجلد 60 (1) · e27479-e27479

OBJECTIVE: Recently, angiotensin-converting enzyme 2 (ACE2) gene has emerged as a potential candidate gene for susceptibility to SARS-CoV-2 infection. We investigated whether ACE2 G8790A (rs2285666) polymorphism could be a genetic marker for susceptibility to COVID-19 and disease severity in Egyptian children and adolescents. METHODS: This was a prospective case-control study included 580 cases diagnosed with COVID-19, and 580 matched control children and adolescents. The ACE2 G8790A (rs2285666) polymorphism was genotyped using polymerase chain reaction (PCR) and ACE2 serum level was measured by ELISA. RESULTS: The ACE2 A/A genotype and A-allele were significantly more represented in cases with COVID-19 as compared to control group (44% vs. 30%; OR = 2.83; [95% CI: 1.27-2.63]; p = 0.006; for the A/A genotype) and (65% vs. 51%; OR = 1.9; [95% CI: 1.06-1.72]; p = 0.01; for the A-allele). The presence of ACE2 G/G genotype was an independent risk factor for severe disease (adjusted OR: 2.08; [95% CI: 1.57-6.78]; p = 0.003). CONCLUSION: The ACE2 G8790A (rs2285666) polymorphism may confer susceptibility to COVID-19 in Egyptian children and adolescents. The ACE2 G/G genotype and G-allele was associated with lower ACE2 serum levels and may constitute independent risk factors for disease severity.

COVID-19 pandemicSARS-CoV-2ACE2 geners2285666